XNYS 04 May, 2026 5:30 PM (EDT)
| Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|
| Charles R. Schwab | Director, Co-Chairman | Sale of securities on an exchange or to another person at price $ 90.50 per share. | 23 Apr 2026 | 36,450 | 55,709,834 (4%) | 0% | 90.5 | 3,298,769 | Common Stock |
| Charles R. Schwab | Director, Co-Chairman | Sale of securities on an exchange or to another person at price $ 90.00 per share. | 23 Apr 2026 | 36,450 | 55,673,384 (4%) | 0% | 90.0 | 3,280,562 | Common Stock |
| Nigel J. Murtagh | Chief Risk Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Apr 2026 | 41,297 | 0 | - | - | Nonqualified Stock Option (right to buy) | |
| Nigel J. Murtagh | Chief Risk Officer | Sale of securities on an exchange or to another person at price $ 99.00 per share. | 14 Apr 2026 | 41,297 | 57,972 (0%) | 0% | 99.0 | 4,088,523 | Common Stock |
| Nigel J. Murtagh | Chief Risk Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 52.05 per share. | 14 Apr 2026 | 41,297 | 99,269 (0%) | 0% | 52.1 | 2,149,509 | Common Stock |
| Jonathan M. Craig | MD, Head of Retail Investing | Exercise or conversion of derivative security received from the company (such as an option) at price $ 46.81 per share. | 14 Apr 2026 | 21,750 | 0 (0%) | 0% | 46.8 | 1,018,118 | Common Stock |
| Jonathan M. Craig | MD, Head of Retail Investing | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Apr 2026 | 21,750 | 65,366 | - | - | Nonqualified Stock Option (right to buy) | |
| Jonathan M. Craig | MD, Head of Retail Investing | Sale of securities on an exchange or to another person at price $ 99.00 per share. | 14 Apr 2026 | 21,750 | 0 (0%) | 0% | 99.0 | 2,153,326 | Common Stock |
| Paul V. Woolway | MD, Chief Banking Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 52.05 per share. | 14 Apr 2026 | 7,941 | 25,153 (0%) | 0% | 52.0 | 413,329 | Common Stock |
| Paul V. Woolway | MD, Chief Banking Officer | Sale of securities on an exchange or to another person at price $ 98.00 per share. | 14 Apr 2026 | 7,942 | 29,866 (0%) | 0% | 98.0 | 778,342 | Common Stock |
| Paul V. Woolway | MD, Chief Banking Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 52.05 per share. | 14 Apr 2026 | 7,942 | 25,153 (0%) | 0% | 52.0 | 413,381 | Common Stock |
| Paul V. Woolway | MD, Chief Banking Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Apr 2026 | 7,941 | 0 | - | - | Nonqualified Stock Option (right to buy) | |
| Paul V. Woolway | MD, Chief Banking Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Apr 2026 | 7,942 | 7,941 | - | - | Nonqualified Stock Option (right to buy) | |
| Paul V. Woolway | MD, Chief Banking Officer | Sale of securities on an exchange or to another person at price $ 100.00 per share. | 14 Apr 2026 | 7,941 | 29,866 (0%) | 0% | 100.0 | 794,137 | Common Stock |
| Frank C. Herringer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2026 | 474 | 151,757 | - | - | Restricted Stock Units | |
| Stephen A. Ellis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2026 | 393 | 12,851 | - | - | Restricted Stock Units | |
| Marianne C. Brown | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2026 | 434 | 7,823 | - | - | Restricted Stock Units | |
| Charles A. Ruffel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2026 | 1,286 | 1,286 | - | - | Nonqualified Stock Option (right to buy) | |
| Stephen A. Ellis | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 28.38 per share. | 24 Mar 2026 | 1,899 | 6,660 (0%) | 0% | 28.4 | 53,894 | Common Stock |
| Stephen A. Ellis | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Mar 2026 | 7,866 | 0 | - | - | Nonqualified Stock Option (right to buy) | |
| Stephen A. Ellis | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Mar 2026 | 1,899 | 0 | - | - | Nonqualified Stock Option (right to buy) | |
| Stephen A. Ellis | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 28.96 per share. | 24 Mar 2026 | 7,866 | 6,660 (0%) | 0% | 29.0 | 227,799 | Common Stock |
| Nigel J. Murtagh | Chief Risk Officer | Sale of securities on an exchange or to another person at price $ 94.43 per share. | 03 Mar 2026 | 4,463 | 60,712 (0%) | 0% | 94.4 | 421,429 | Common Stock |
| Nigel J. Murtagh | Chief Risk Officer | Sale of securities on an exchange or to another person at price $ 94.90 per share. | 03 Mar 2026 | 2,740 | 57,972 (0%) | 0% | 94.9 | 260,024 | Common Stock |
| Jonathan M. Craig | MD, Head of Investor Services | Sale of securities on an exchange or to another person at price $ 94.89 per share. | 03 Mar 2026 | 5,449 | 0 (0%) | 0% | 94.9 | 517,079 | Common Stock |
| Jonathan M. Craig | MD, Head of Investor Services | Sale of securities on an exchange or to another person at price $ 94.42 per share. | 03 Mar 2026 | 9,032 | 5,449 (0%) | 0% | 94.4 | 852,818 | Common Stock |
| Michael D. Verdeschi | CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2026 | 62,134 | 62,134 | - | - | Nonqualified Stock Option (right to buy) | |
| Jonathan S. Beatty | MD, Head of Advisor Services | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2026 | 24,509 | 24,509 | - | - | Nonqualified Stock Option (right to buy) | |
| Charles R. Schwab | Director, Co-Chairman | Payment of exercise price or tax liability using portion of securities received from the company at price $ 95.30 per share. | 01 Mar 2026 | 15,283 | 0 (0%) | 0% | 95.3 | 1,456,546 | Common Stock |
| Charles R. Schwab | Director, Co-Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2026 | 38,838 | 38,838 (0%) | 0% | 0 | Common Stock | |
| Charles R. Schwab | Director, Co-Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2026 | 72,489 | 72,489 | - | - | Nonqualified Stock Option (right to buy) | |
| Walter W. Bettinger | Director, Co-Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2026 | 141,757 | 141,757 (0%) | 0% | 0 | Common Stock | |
| Walter W. Bettinger | Director, Co-Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2026 | 42,113 | 42,113 | - | - | Nonqualified Stock Option (right to buy) | |
| Walter W. Bettinger | Director, Co-Chairman | Payment of exercise price or tax liability using portion of securities received from the company at price $ 95.31 per share. | 01 Mar 2026 | 60,743 | 81,014 (0%) | 0% | 95.3 | 5,789,112 | Common Stock |
| Nigel J. Murtagh | Chief Risk Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 95.30 per share. | 01 Mar 2026 | 9,109 | 65,175 (0%) | 0% | 95.3 | 868,133 | Common Stock |
| Nigel J. Murtagh | Chief Risk Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2026 | 16,312 | 74,284 (0%) | 0% | 0 | Common Stock | |
| Nigel J. Murtagh | Chief Risk Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2026 | 30,377 | 30,377 | - | - | Nonqualified Stock Option (right to buy) | |
| Jonathan M. Craig | MD, Head of Investor Services | Payment of exercise price or tax liability using portion of securities received from the company at price $ 95.30 per share. | 01 Mar 2026 | 11,152 | 14,481 (0%) | 0% | 95.3 | 1,062,841 | Common Stock |
| Jonathan M. Craig | MD, Head of Investor Services | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2026 | 25,633 | 25,633 (0%) | 0% | 0 | Common Stock | |
| Jonathan M. Craig | MD, Head of Investor Services | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2026 | 50,052 | 50,052 | - | - | Nonqualified Stock Option (right to buy) | |
| Peter J. Morgan | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2026 | 11,263 | 11,263 (0%) | 0% | 0 | Common Stock | |
| Peter J. Morgan | General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 95.31 per share. | 01 Mar 2026 | 4,311 | 6,952 (0%) | 0% | 95.3 | 410,860 | Common Stock |
| Peter J. Morgan | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2026 | 21,057 | 21,057 | - | - | Nonqualified Stock Option (right to buy) | |
| Richard A. Wurster | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 95.30 per share. | 01 Mar 2026 | 22,879 | 196,450 (0%) | 0% | 95.3 | 2,180,483 | Common Stock |
| Richard A. Wurster | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2026 | 230,411 | 230,411 | - | - | Nonqualified Stock Option (right to buy) | |
| Richard A. Wurster | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2026 | 62,140 | 219,329 (0%) | 0% | 0 | Common Stock | |
| Paul V. Woolway | MD, Chief Banking Officer | Sale of securities on an exchange or to another person at price $ 94.41 per share. | 01 Mar 2026 | 3,626 | 32,366 (0%) | 0% | 94.4 | 342,347 | Common Stock |
| Paul V. Woolway | MD, Chief Banking Officer | Sale of securities on an exchange or to another person at price $ 94.89 per share. | 01 Mar 2026 | 2,500 | 29,866 (0%) | 0% | 94.9 | 237,226 | Common Stock |
| Paul V. Woolway | MD, Chief Banking Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2026 | 15,884 | 15,883 | - | - | Nonqualified Stock Option (right to buy) | |
| Paul V. Woolway | MD, Chief Banking Officer | Sale of securities on an exchange or to another person at price $ 96.00 per share. | 01 Mar 2026 | 7,942 | 35,992 (0%) | 0% | 96.0 | 762,442 | Common Stock |
| Paul V. Woolway | MD, Chief Banking Officer | Sale of securities on an exchange or to another person at price $ 94.23 per share. | 01 Mar 2026 | 7,942 | 43,934 (0%) | 0% | 94.2 | 748,375 | Common Stock |
| Paul V. Woolway | MD, Chief Banking Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 52.05 per share. | 01 Mar 2026 | 15,884 | 25,153 (0%) | 0% | 52.0 | 826,762 | Common Stock |
| Paul V. Woolway | MD, Chief Banking Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 90.30 per share. | 01 Mar 2026 | 2,030 | 35,992 (0%) | 0% | 90.3 | 183,319 | Common Stock |
| Paul V. Woolway | MD, Chief Banking Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2026 | 8,156 | 38,022 (0%) | 0% | 0 | Common Stock | |
| Paul V. Woolway | MD, Chief Banking Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2026 | 15,189 | 15,189 | - | - | Nonqualified Stock Option (right to buy) | |
| Jonathan S. Beatty | MD, Head of Advisor Services | Sale of securities on an exchange or to another person at price $ 95.30 per share. | 27 Feb 2026 | 2,030 | 19,738 (0%) | 0% | 95.3 | 193,454 | Common Stock |
| Stephen A. Ellis | Director | Sale of securities on an exchange or to another person at price $ 96.57 per share. | 26 Feb 2026 | 10,725 | 87,562 (0%) | 0% | 96.6 | 1,035,694 | Common Stock |
| Charles R. Schwab | Director, Co-Chairman | Gift of securities by or to the insider at price $ 0.00 per share. | 09 Feb 2026 | 60,000 | 55,722,729 (4%) | 0% | 0 | Common Stock | |
| Charles R. Schwab | Director, Co-Chairman | Sale of securities on an exchange or to another person at price $ 105.58 per share. | 09 Feb 2026 | 32,413 | 30,483,368 (2%) | 0% | 105.6 | 3,422,080 | Common Stock |
| Charles R. Schwab | Director, Co-Chairman | Sale of securities on an exchange or to another person at price $ 106.55 per share. | 09 Feb 2026 | 126,200 | 30,515,781 (2%) | 0% | 106.5 | 13,446,547 | Common Stock |
| Christopher V. Dodds | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2026 | 2,732 | 2,732 | - | - | Nonqualified Stock Option (right to buy) | |
| Christopher V. Dodds | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2026 | 4,703 | 0 | - | - | Nonqualified Stock Option (right to buy) | |
| Christopher V. Dodds | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2026 | 4,390 | 0 | - | - | Nonqualified Stock Option (right to buy) | |
| Christopher V. Dodds | Director | Sale of securities on an exchange or to another person at price $ 104.55 per share. | 06 Feb 2026 | 11,825 | 449,406 (0%) | 0% | 104.6 | 1,236,314 | Common Stock |
| Christopher V. Dodds | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 73.00 per share. | 06 Feb 2026 | 4,390 | 453,796 (0%) | 0% | 73 | 320,470 | Common Stock |
| Christopher V. Dodds | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 62.66 per share. | 06 Feb 2026 | 4,703 | 458,499 (0%) | 0% | 62.7 | 294,690 | Common Stock |
| Christopher V. Dodds | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 51.97 per share. | 06 Feb 2026 | 2,732 | 461,231 (0%) | 0% | 52.0 | 141,982 | Common Stock |
| Walter W. Bettinger | Director, Co-Chairman | Sale of securities on an exchange or to another person at price $ 104.25 per share. | 06 Feb 2026 | 67,514 | 529,346 (0%) | 0% | 104.3 | 7,038,476 | Common Stock |
| Walter W. Bettinger | Director, Co-Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 42.99 per share. | 06 Feb 2026 | 67,514 | 596,860 (0%) | 0% | 43.0 | 2,902,427 | Common Stock |
| Walter W. Bettinger | Director, Co-Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2026 | 67,514 | 0 | - | - | Nonqualified Stock Option (right to buy) | |
| Charles R. Schwab | Director, Co-Chairman | Sale of securities on an exchange or to another person at price $ 103.81 per share. | 03 Feb 2026 | 67,975 | 55,782,729 (4%) | 0% | 103.8 | 7,056,424 | Common Stock |
| Charles R. Schwab | Director, Co-Chairman | Sale of securities on an exchange or to another person at price $ 103.74 per share. | 03 Feb 2026 | 96,625 | 55,850,704 (4%) | 0% | 103.7 | 10,023,530 | Common Stock |
| Walter W. Bettinger | Director, Co-Chairman | Sale of securities on an exchange or to another person at price $ 104.25 per share. | 03 Feb 2026 | 94,948 | 529,346 (0%) | 0% | 104.3 | 9,898,519 | Common Stock |
| Walter W. Bettinger | Director, Co-Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 42.99 per share. | 03 Feb 2026 | 94,948 | 624,294 (0%) | 0% | 43.0 | 4,081,815 | Common Stock |
| Walter W. Bettinger | Director, Co-Chairman | Sale of securities on an exchange or to another person at price $ 104.24 per share. | 03 Feb 2026 | 21,429 | 529,346 (0%) | 0% | 104.2 | 2,233,821 | Common Stock |
| Walter W. Bettinger | Director, Co-Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 42.99 per share. | 03 Feb 2026 | 162,462 | 691,808 (0%) | 0% | 43.0 | 6,984,241 | Common Stock |
| Walter W. Bettinger | Director, Co-Chairman | Sale of securities on an exchange or to another person at price $ 103.85 per share. | 03 Feb 2026 | 141,033 | 550,775 (0%) | 0% | 103.8 | 14,646,066 | Common Stock |
| Walter W. Bettinger | Director, Co-Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2026 | 94,948 | 67,514 | - | - | Nonqualified Stock Option (right to buy) | |
| Walter W. Bettinger | Director, Co-Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2026 | 162,462 | 162,462 | - | - | Nonqualified Stock Option (right to buy) | |
| Peter J. Morgan | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 66.47 per share. | 02 Feb 2026 | 7,595 | 7,595 (0%) | 0% | 66.5 | 504,840 | Common Stock |
| Peter J. Morgan | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Feb 2026 | 7,595 | 22,788 | - | - | Nonqualified Stock Option (right to buy) | |
| Peter J. Morgan | General Counsel | Sale of securities on an exchange or to another person at price $ 104.38 per share. | 02 Feb 2026 | 7,595 | 0 (0%) | 0% | 104.4 | 792,796 | Common Stock |
| Charles R. Schwab | Director, Co-Chairman | Sale of securities on an exchange or to another person at price $ 103.16 per share. | 29 Jan 2026 | 145,650 | 55,947,329 (4%) | 0% | 103.2 | 15,025,968 | Common Stock |
| Charles R. Schwab | Director, Co-Chairman | Sale of securities on an exchange or to another person at price $ 103.20 per share. | 26 Jan 2026 | 44,962 | 56,119,454 (4%) | 0% | 103.2 | 4,640,092 | Common Stock |
| Charles R. Schwab | Director, Co-Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 26.39 per share. | 26 Jan 2026 | 134,895 | 0 (0%) | 0% | 26.4 | 3,559,879 | Common Stock |
| Charles R. Schwab | Director, Co-Chairman | Sale of securities on an exchange or to another person at price $ 103.09 per share. | 26 Jan 2026 | 134,895 | 56,119,454 (4%) | 0% | 103.1 | 13,905,840 | Common Stock |
| Charles R. Schwab | Director, Co-Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 26.39 per share. | 26 Jan 2026 | 44,962 | 0 (0%) | 0% | 26.4 | 1,186,547 | Common Stock |
| Charles R. Schwab | Director, Co-Chairman | Sale of securities on an exchange or to another person at price $ 103.22 per share. | 26 Jan 2026 | 26,475 | 56,092,979 (4%) | 0% | 103.2 | 2,732,689 | Common Stock |
| Charles R. Schwab | Director, Co-Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Jan 2026 | 44,962 | 0 | - | - | Nonqualified Stock Option (right to buy) | |
| Charles R. Schwab | Director, Co-Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Jan 2026 | 134,895 | 44,962 | - | - | Nonqualified Stock Option (right to buy) | |
| Jonathan S. Beatty | MD, Head of Advisor Services | Sale of securities on an exchange or to another person at price $ 105.00 per share. | 22 Jan 2026 | 2,000 | 21,768 (0%) | 0% | 105.0 | 210,003 | Common Stock |
| Jonathan S. Beatty | MD, Head of Advisor Services | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Jan 2026 | 2,000 | 0 | - | - | Nonqualified Stock Option (right to buy) | |
| Jonathan S. Beatty | MD, Head of Advisor Services | Exercise or conversion of derivative security received from the company (such as an option) at price $ 46.39 per share. | 22 Jan 2026 | 2,000 | 33,495 (0%) | 0% | 46.4 | 92,780 | Common Stock |
| Carolyn Schwab-Pomerantz | Director | Sale of securities on an exchange or to another person at price $ 105.18 per share. | 22 Jan 2026 | 9,525 | 1,396,458 (0%) | 0% | 105.2 | 1,001,792 | Common Stock |
| Carolyn Schwab-Pomerantz | Director | Sale of securities on an exchange or to another person at price $ 105.25 per share. | 22 Jan 2026 | 19,050 | 1,415,508 (0%) | 0% | 105.2 | 2,004,961 | Common Stock |
| Carolyn Schwab-Pomerantz | Director | Sale of securities on an exchange or to another person at price $ 105.19 per share. | 22 Jan 2026 | 9,525 | 1,405,983 (0%) | 0% | 105.2 | 1,001,928 | Common Stock |
| Carolyn Schwab-Pomerantz | Director | Sale of securities on an exchange or to another person at price $ 105.02 per share. | 22 Jan 2026 | 4,765 | 436,149 (0%) | 0% | 105.0 | 500,400 | Common Stock |
| Frank C. Herringer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2026 | 431 | 150,782 | - | - | Restricted Stock Units | |
| Stephen A. Ellis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2026 | 357 | 12,417 | - | - | Restricted Stock Units | |
| Marianne C. Brown | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2026 | 394 | 7,365 | - | - | Restricted Stock Units | |
| Charles A. Ruffel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2026 | 1,317 | 1,317 | - | - | Nonqualified Stock Option (right to buy) | |
| Jonathan S. Beatty | MD, Head of Advisor Services | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Dec 2025 | 2,000 | 2,000 | - | - | Nonqualified Stock Option (right to buy) | |
| Jonathan S. Beatty | MD, Head of Advisor Services | Sale of securities on an exchange or to another person at price $ 102.01 per share. | 23 Dec 2025 | 2,000 | 11,923 (0%) | 0% | 102.0 | 204,022 | Common Stock |
| Jonathan S. Beatty | MD, Head of Advisor Services | Exercise or conversion of derivative security received from the company (such as an option) at price $ 46.39 per share. | 23 Dec 2025 | 2,000 | 43,340 (0%) | 0% | 46.4 | 92,780 | Common Stock |
| Stephen A. Ellis | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Dec 2025 | 1,922 | 0 | - | - | Nonqualified Stock Option (right to buy) | |
| Stephen A. Ellis | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 31.98 per share. | 16 Dec 2025 | 1,922 | 6,660 (0%) | 0% | 32.0 | 61,466 | Common Stock |
| Charles A. Ruffel | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 19 Nov 2025 | 8,372 | 9,778 (0%) | 0% | 0 | Common Stock | |
| Paula A. Sneed | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 13 Nov 2025 | 8,680 | 96,974 (0%) | 0% | 0 | Common Stock | |
| Charles R. Schwab | Director, Co-Chairman | Gift of securities by or to the insider at price $ 0.00 per share. | 12 Nov 2025 | 52,500 | 56,119,454 (4%) | 0% | 0 | Common Stock | |
| Nigel J. Murtagh | Chief Risk Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 12 Nov 2025 | 1,032 | 57,972 (0%) | 0% | 0 | Common Stock | |
| Jonathan S. Beatty | MD, Head of Advisor Services | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Nov 2025 | 3,072 | 4,000 | - | - | Nonqualified Stock Option (right to buy) | |
| Jonathan S. Beatty | MD, Head of Advisor Services | Sale of securities on an exchange or to another person at price $ 98.00 per share. | 12 Nov 2025 | 3,072 | 11,923 (0%) | 0% | 98 | 301,056 | Common Stock |
| Jonathan S. Beatty | MD, Head of Advisor Services | Exercise or conversion of derivative security received from the company (such as an option) at price $ 46.39 per share. | 12 Nov 2025 | 3,072 | 43,340 (0%) | 0% | 46.4 | 142,510 | Common Stock |
| Paul V. Woolway | MD, Chief Banking Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 10 Nov 2025 | 1,089 | 29,866 (0%) | 0% | 0 | Common Stock | |
| Paul V. Woolway | MD, Chief Banking Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 10 Nov 2025 | 398 | 1,536 (0%) | 0% | 0 | Common Stock | |
| Paul V. Woolway | MD, Chief Banking Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 10 Nov 2025 | 398 | 1,536 (0%) | 0% | 0 | Common Stock | |
| Walter W. Bettinger | Director, Co-Chairman | Gift of securities by or to the insider at price $ 0.00 per share. | 10 Nov 2025 | 61,388 | 529,346 (0%) | 0% | 0 | Common Stock | |
| Carolyn Schwab-Pomerantz | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 10 Nov 2025 | 298 | 1,434,558 (0%) | 0% | 0 | Common Stock | |
| Jonathan M. Craig | MD, Head of Investor Services | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Nov 2025 | 35,188 | 0 | - | - | Nonqualified Stock Option (right to buy) | |
| Jonathan M. Craig | MD, Head of Investor Services | Exercise or conversion of derivative security received from the company (such as an option) at price $ 41.98 per share. | 07 Nov 2025 | 35,188 | 0 (0%) | 0% | 42.0 | 1,477,192 | Common Stock |
| Jonathan M. Craig | MD, Head of Investor Services | Sale of securities on an exchange or to another person at price $ 95.35 per share. | 07 Nov 2025 | 35,188 | 0 (0%) | 0% | 95.3 | 3,355,028 | Common Stock |
| Paul V. Woolway | MD, Chief Banking Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 29 Oct 2025 | 3,822 | 30,955 (0%) | 0% | 0 | Common Stock | |
| Charles R. Schwab | Director, Co-Chairman | Sale of securities on an exchange or to another person at price $ 94.00 per share. | 28 Oct 2025 | 64,400 | 56,216,704 (4%) | 0% | 94.0 | 6,053,909 | Common Stock |
| Charles R. Schwab | Director, Co-Chairman | Sale of securities on an exchange or to another person at price $ 94.52 per share. | 28 Oct 2025 | 44,750 | 56,171,954 (4%) | 0% | 94.5 | 4,229,815 | Common Stock |
| Charles R. Schwab | Director, Co-Chairman | Gift of securities by or to the insider at price $ 0.00 per share. | 23 Oct 2025 | 18,595 | 56,312,854 (4%) | 0% | 0 | Common Stock | |
| Charles R. Schwab | Director, Co-Chairman | Gift of securities by or to the insider at price $ 0.00 per share. | 23 Oct 2025 | 31,750 | 56,281,104 (4%) | 0% | 0 | Common Stock | |
| Carolyn Schwab-Pomerantz | Director | Sale of securities on an exchange or to another person at price $ 92.55 per share. | 02 Oct 2025 | 14,400 | 1,434,856 (0%) | 0% | 92.5 | 1,332,670 | Common Stock |
| Carolyn Schwab-Pomerantz | Director | Sale of securities on an exchange or to another person at price $ 92.55 per share. | 02 Oct 2025 | 9,600 | 440,914 (0%) | 0% | 92.6 | 888,523 | Common Stock |
| Paul V. Woolway | MD, Chief Banking Officer | Sale of securities on an exchange or to another person at price $ 93.04 per share. | 01 Oct 2025 | 1,913 | 36,070 (0%) | 0% | 93.0 | 177,995 | Common Stock |
| Paul V. Woolway | MD, Chief Banking Officer | Sale of securities on an exchange or to another person at price $ 93.74 per share. | 01 Oct 2025 | 1,292 | 34,778 (0%) | 0% | 93.7 | 121,116 | Common Stock |
| Frank C. Herringer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2025 | 921 | 921 | - | - | Nonqualified Stock Option (right to buy) | |
| Frank C. Herringer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2025 | 224 | 149,911 | - | - | Restricted Stock Units | |
| Stephen A. Ellis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2025 | 366 | 12,025 | - | - | Restricted Stock Units | |
| Marianne C. Brown | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2025 | 407 | 6,950 | - | - | Restricted Stock Units | |
| Charles A. Ruffel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2025 | 1,340 | 1,340 | - | - | Nonqualified Stock Option (right to buy) | |
| Stephen A. Ellis | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 28.55 per share. | 23 Sep 2025 | 2,105 | 6,660 (0%) | 0% | 28.6 | 60,098 | Common Stock |
| Stephen A. Ellis | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Sep 2025 | 2,105 | 0 | - | - | Nonqualified Stock Option (right to buy) | |
| Carolyn Schwab-Pomerantz | Director | Sale of securities on an exchange or to another person at price $ 96.64 per share. | 04 Sep 2025 | 14,400 | 1,449,256 (0%) | 0% | 96.6 | 1,391,583 | Common Stock |
| Carolyn Schwab-Pomerantz | Director | Sale of securities on an exchange or to another person at price $ 96.64 per share. | 04 Sep 2025 | 9,600 | 450,514 (0%) | 0% | 96.6 | 927,717 | Common Stock |
| Paul V. Woolway | MD, Chief Banking Officer | Sale of securities on an exchange or to another person at price $ 95.20 per share. | 02 Sep 2025 | 3,205 | 37,983 (0%) | 0% | 95.2 | 305,127 | Common Stock |
| Peter J. Morgan | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 64.10 per share. | 27 Aug 2025 | 47,813 | 50,016 (0%) | 0% | 64.1 | 3,064,813 | Common Stock |
| Peter J. Morgan | General Counsel | Sale of securities on an exchange or to another person at price $ 97.00 per share. | 27 Aug 2025 | 50,016 | 0 (0%) | 0% | 97.0 | 4,851,572 | Common Stock |
| Peter J. Morgan | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 46.39 per share. | 27 Aug 2025 | 2,203 | 2,203 (0%) | 0% | 46.4 | 102,197 | Common Stock |
| Peter J. Morgan | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Aug 2025 | 47,813 | 0 | - | - | Nonqualified Stock Option (right to buy) | |
| Peter J. Morgan | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Aug 2025 | 2,203 | 0 | - | - | Nonqualified Stock Option (right to buy) | |
| Jonathan S. Beatty | MD, Head of Advisor Services | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Aug 2025 | 6,144 | 7,072 | - | - | Nonqualified Stock Option (right to buy) | |
| Jonathan S. Beatty | MD, Head of Advisor Services | Sale of securities on an exchange or to another person at price $ 96.81 per share. | 27 Aug 2025 | 6,144 | 11,923 (0%) | 0% | 96.8 | 594,809 | Common Stock |
| Jonathan S. Beatty | MD, Head of Advisor Services | Exercise or conversion of derivative security received from the company (such as an option) at price $ 46.39 per share. | 27 Aug 2025 | 6,144 | 43,340 (0%) | 0% | 46.4 | 285,020 | Common Stock |
| Jonathan S. Beatty | MD, Head of Advisor Services | Sale of securities on an exchange or to another person at price $ 97.18 per share. | 27 Aug 2025 | 3,296 | 11,923 (0%) | 0% | 97.2 | 320,305 | Common Stock |
| Charles R. Schwab | Director, Co-Chairman | Sale of securities on an exchange or to another person at price $ 96.67 per share. | 26 Aug 2025 | 136,500 | 56,467,949 (4%) | 0% | 96.7 | 13,194,909 | Common Stock |
| Charles R. Schwab | Director, Co-Chairman | Sale of securities on an exchange or to another person at price $ 97.04 per share. | 26 Aug 2025 | 136,500 | 56,331,449 (4%) | 0% | 97.0 | 13,246,506 | Common Stock |
| Carolyn Schwab-Pomerantz | Director | Sale of securities on an exchange or to another person at price $ 96.06 per share. | 25 Aug 2025 | 13,542 | 1,463,656 (0%) | 0% | 96.1 | 1,300,803 | Common Stock |
| Carolyn Schwab-Pomerantz | Director | Sale of securities on an exchange or to another person at price $ 96.68 per share. | 07 Aug 2025 | 14,000 | 1,477,598 (0%) | 0% | 96.7 | 1,353,519 | Common Stock |
| Carolyn Schwab-Pomerantz | Director | Sale of securities on an exchange or to another person at price $ 97.20 per share. | 07 Aug 2025 | 200 | 460,114 (0%) | 0% | 97.2 | 19,441 | Common Stock |
| Carolyn Schwab-Pomerantz | Director | Sale of securities on an exchange or to another person at price $ 96.68 per share. | 07 Aug 2025 | 9,400 | 460,314 (0%) | 0% | 96.7 | 908,809 | Common Stock |
| Carolyn Schwab-Pomerantz | Director | Sale of securities on an exchange or to another person at price $ 97.22 per share. | 07 Aug 2025 | 400 | 1,477,198 (0%) | 0% | 97.2 | 38,888 | Common Stock |
| Charles R. Schwab | Director, Co-Chairman | Sale of securities on an exchange or to another person at price $ 96.02 per share. | 07 Aug 2025 | 22,721 | 56,737,602 (4%) | 0% | 96.0 | 2,181,611 | Common Stock |
| Charles R. Schwab | Director, Co-Chairman | Sale of securities on an exchange or to another person at price $ 96.84 per share. | 07 Aug 2025 | 104,500 | 56,604,449 (4%) | 0% | 96.8 | 10,120,146 | Common Stock |
| Charles R. Schwab | Director, Co-Chairman | Sale of securities on an exchange or to another person at price $ 96.60 per share. | 07 Aug 2025 | 28,653 | 56,708,949 (4%) | 0% | 96.6 | 2,767,934 | Common Stock |
| Paul V. Woolway | MD, Chief Banking Officer | Sale of securities on an exchange or to another person at price $ 96.06 per share. | 01 Aug 2025 | 3,290 | 41,188 (0%) | 0% | 96.1 | 316,043 | Common Stock |
| Walter W. Bettinger | Director, Co-Chairman | Sale of securities on an exchange or to another person at price $ 98.84 per share. | 29 Jul 2025 | 173,876 | 590,734 (0%) | 0% | 98.8 | 17,186,391 | Common Stock |
| Joan T. Dea | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 29 Jul 2025 | 513 | 27,673 (0%) | 0% | 0 | Common Stock | |
| Nigel J. Murtagh | Chief Risk Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 41.98 per share. | 29 Jul 2025 | 24,096 | 83,095 (0%) | 0% | 42.0 | 1,011,550 | Common Stock |
| Nigel J. Murtagh | Chief Risk Officer | Sale of securities on an exchange or to another person at price $ 97.91 per share. | 29 Jul 2025 | 24,096 | 58,999 (0%) | 0% | 97.9 | 2,359,290 | Common Stock |
| Nigel J. Murtagh | Chief Risk Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jul 2025 | 24,096 | 0 | - | - | Nonqualified Stock Option (right to buy) | |
| Richard A. Wurster | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 99.16 per share. | 29 Jul 2025 | 20,500 | 157,189 (0%) | 0% | 99.2 | 2,032,852 | Common Stock |
| Carolyn Schwab-Pomerantz | Director | Sale of securities on an exchange or to another person at price $ 91.59 per share. | 03 Jul 2025 | 9,600 | 469,714 (0%) | 0% | 91.6 | 879,250 | Common Stock |
| Carolyn Schwab-Pomerantz | Director | Sale of securities on an exchange or to another person at price $ 91.59 per share. | 03 Jul 2025 | 14,400 | 1,491,598 (0%) | 0% | 91.6 | 1,318,905 | Common Stock |
| Jonathan S. Beatty | MD, Head of Advisor Services | Payment of exercise price or tax liability using portion of securities received from the company at price $ 90.74 per share. | 01 Jul 2025 | 1,035 | 43,340 (0%) | 0% | 90.7 | 93,913 | Common Stock |
| Paul V. Woolway | MD, Chief Banking Officer | Sale of securities on an exchange or to another person at price $ 90.95 per share. | 01 Jul 2025 | 3,290 | 35,864 (0%) | 0% | 90.9 | 299,220 | Common Stock |
| Frank C. Herringer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2025 | 227 | 149,266 | - | - | Restricted Stock Units | |
| Frank C. Herringer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2025 | 909 | 909 | - | - | Nonqualified Stock Option (right to buy) | |
| Stephen A. Ellis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2025 | 371 | 11,626 | - | - | Restricted Stock Units | |
| Marianne C. Brown | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2025 | 412 | 6,525 | - | - | Restricted Stock Units | |
| Charles A. Ruffel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2025 | 1,322 | 1,322 | - | - | Nonqualified Stock Option (right to buy) | |
| Stephen A. Ellis | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 33.12 per share. | 24 Jun 2025 | 1,853 | 6,660 (0%) | 0% | 33.1 | 61,371 | Common Stock |
| Stephen A. Ellis | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Jun 2025 | 1,853 | 0 | - | - | Nonqualified Stock Option (right to buy) | |
| Paul V. Woolway | MD, Chief Banking Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 46.81 per share. | 18 Jun 2025 | 10,129 | 33,767 (0%) | 0% | 46.8 | 474,138 | Common Stock |
| Paul V. Woolway | MD, Chief Banking Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Jun 2025 | 10,129 | 10,131 | - | - | Nonqualified Stock Option (right to buy) | |
| Paul V. Woolway | MD, Chief Banking Officer | Sale of securities on an exchange or to another person at price $ 90.01 per share. | 18 Jun 2025 | 10,129 | 39,154 (0%) | 0% | 90.0 | 911,684 | Common Stock |
| Nigel J. Murtagh | Chief Risk Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 42.99 per share. | 18 Jun 2025 | 20,872 | 79,871 (0%) | 0% | 43.0 | 897,287 | Common Stock |
| Nigel J. Murtagh | Chief Risk Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Jun 2025 | 20,872 | 0 | - | - | Nonqualified Stock Option (right to buy) | |
| Nigel J. Murtagh | Chief Risk Officer | Sale of securities on an exchange or to another person at price $ 90.01 per share. | 18 Jun 2025 | 20,872 | 58,999 (0%) | 0% | 90.0 | 1,878,666 | Common Stock |
| Carolyn Schwab-Pomerantz | Director | Sale of securities on an exchange or to another person at price $ 87.25 per share. | 05 Jun 2025 | 9,600 | 479,314 (0%) | 0% | 87.2 | 837,592 | Common Stock |
| Carolyn Schwab-Pomerantz | Director | Sale of securities on an exchange or to another person at price $ 87.25 per share. | 05 Jun 2025 | 14,400 | 1,505,998 (0%) | 0% | 87.2 | 1,256,364 | Common Stock |
| Michael D. Verdeschi | CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 87.54 per share. | 03 Jun 2025 | 5,888 | 53,961 (0%) | 0% | 87.5 | 515,436 | Common Stock |
| Paul V. Woolway | MD, Chief Banking Officer | Sale of securities on an exchange or to another person at price $ 87.68 per share. | 02 Jun 2025 | 3,290 | 39,154 (0%) | 0% | 87.7 | 288,452 | Common Stock |
| Jonathan S. Beatty | MD, Head of Advisor Services | Sale of securities on an exchange or to another person at price $ 87.57 per share. | 30 May 2025 | 2,850 | 15,219 (0%) | 0% | 87.6 | 249,572 | Common Stock |
| Nigel J. Murtagh | Chief Risk Officer | Sale of securities on an exchange or to another person at price $ 88.20 per share. | 28 May 2025 | 25,000 | 58,999 (0%) | 0% | 88.2 | 2,205,105 | Common Stock |
| Nigel J. Murtagh | Chief Risk Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 May 2025 | 25,000 | 24,096 | - | - | Nonqualified Stock Option (right to buy) | |
| Nigel J. Murtagh | Chief Risk Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 41.98 per share. | 28 May 2025 | 25,000 | 83,999 (0%) | 0% | 42.0 | 1,049,500 | Common Stock |
| Christopher V. Dodds | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2025 | 3,646 | 3,646 | - | - | Nonqualified Stock Option (right to buy) | |
| Christopher V. Dodds | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2025 | 1,462 | 10,666 (0%) | 0% | 0 | Common Stock | |
| Frank C. Herringer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2025 | 1,462 | 10,666 (0%) | 0% | 0 | Common Stock | |
| Frank C. Herringer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2025 | 3,646 | 3,646 | - | - | Nonqualified Stock Option (right to buy) | |
| Paula A. Sneed | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2025 | 3,646 | 3,646 | - | - | Nonqualified Stock Option (right to buy) | |
| Paula A. Sneed | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2025 | 1,462 | 8,073 (0%) | 0% | 0 | Common Stock | |
| Paula A. Sneed | Director | Sale of securities on an exchange or to another person at price $ 88.06 per share. | 27 May 2025 | 8,647 | 105,654 (0%) | 0% | 88.1 | 761,479 | Common Stock |
| Arun Sarin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2025 | 1,462 | 10,666 (0%) | 0% | 0 | Common Stock | |
| Arun Sarin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2025 | 3,646 | 3,646 | - | - | Nonqualified Stock Option (right to buy) | |
| Joan T. Dea | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2025 | 1,462 | 28,186 (0%) | 0% | 0 | Common Stock | |
| Joan T. Dea | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2025 | 3,646 | 3,646 | - | - | Nonqualified Stock Option (right to buy) | |
| Todd M. Ricketts | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2025 | 1,462 | 379,767 (0%) | 0% | 0 | Common Stock | |
| Todd M. Ricketts | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2025 | 3,646 | 3,646 | - | - | Nonqualified Stock Option (right to buy) | |
| Stephen A. Ellis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2025 | 3,646 | 3,646 | - | - | Nonqualified Stock Option (right to buy) | |
| Stephen A. Ellis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2025 | 1,462 | 9,039 (0%) | 0% | 0 | Common Stock | |
| John K. Adams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2025 | 1,462 | 48,666 (0%) | 0% | 0 | Common Stock | |
| John K. Adams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2025 | 3,646 | 3,646 | - | - | Nonqualified Stock Option (right to buy) | |
| Marianne C. Brown | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2025 | 1,462 | 15,751 (0%) | 0% | 0 | Common Stock | |
| Marianne C. Brown | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2025 | 3,646 | 3,646 | - | - | Nonqualified Stock Option (right to buy) | |
| Gerri K. Martin-Flickinger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2025 | 1,462 | 5,767 (0%) | 0% | 0 | Common Stock | |
| Gerri K. Martin-Flickinger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2025 | 3,646 | 3,646 | - | - | Nonqualified Stock Option (right to buy) | |
| Charles A. Ruffel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2025 | 1,462 | 18,110 (0%) | 0% | 0 | Common Stock | |
| Charles A. Ruffel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2025 | 3,646 | 3,646 | - | - | Nonqualified Stock Option (right to buy) | |
| Carolyn Schwab-Pomerantz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2025 | 1,462 | 9,624 (0%) | 0% | 0 | Common Stock | |
| Carolyn Schwab-Pomerantz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2025 | 3,646 | 3,646 | - | - | Nonqualified Stock Option (right to buy) | |
| Peter J. Morgan | General Counsel | Sale of securities on an exchange or to another person at price $ 87.39 per share. | 22 May 2025 | 10,176 | 0 (0%) | 0% | 87.4 | 889,295 | Common Stock |
| Charles R. Schwab | Director, Co-Chairman | Sale of securities on an exchange or to another person at price $ 87.50 per share. | 22 May 2025 | 34,585 | 57,569,203 (4%) | 0% | 87.5 | 3,026,343 | Common Stock |
| Charles A. Ruffel | Director | Sale of securities on an exchange or to another person at price $ 87.65 per share. | 21 May 2025 | 5,556 | 16,593 (0%) | 0% | 87.7 | 486,986 | Common Stock |
| Jonathan M. Craig | MD, Head of Investor Services | Exercise or conversion of derivative security received from the company (such as an option) at price $ 41.98 per share. | 21 May 2025 | 47,500 | 0 (0%) | 0% | 42.0 | 1,994,050 | Common Stock |
| Jonathan M. Craig | MD, Head of Investor Services | Sale of securities on an exchange or to another person at price $ 88.46 per share. | 21 May 2025 | 47,500 | 0 (0%) | 0% | 88.5 | 4,201,636 | Common Stock |
| Jonathan M. Craig | MD, Head of Investor Services | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 May 2025 | 47,500 | 35,188 | - | - | Nonqualified Stock Option (right to buy) | |
| Walter W. Bettinger | Director, Co-Chairman | Sale of securities on an exchange or to another person at price $ 89.00 per share. | 19 May 2025 | 191,523 | 764,610 (0%) | 0% | 89.0 | 17,045,432 | Common Stock |
| Carolyn Schwab-Pomerantz | Director | Sale of securities on an exchange or to another person at price $ 88.73 per share. | 16 May 2025 | 7,215 | 488,914 (0%) | 0% | 88.7 | 640,190 | Common Stock |
| Carolyn Schwab-Pomerantz | Director | Sale of securities on an exchange or to another person at price $ 88.74 per share. | 16 May 2025 | 10,795 | 1,520,398 (0%) | 0% | 88.7 | 957,975 | Common Stock |
| Charles R. Schwab | Director, Co-Chairman | Gift of securities by or to the insider at price $ 0.00 per share. | 12 May 2025 | 80,000 | 58,922,353 (4%) | 0% | 0 | Common Stock | |
| Charles R. Schwab | Director, Co-Chairman | Sale of securities on an exchange or to another person at price $ 85.39 per share. | 12 May 2025 | 120,000 | 59,002,353 (4%) | 0% | 85.4 | 10,247,244 | Common Stock |
| Richard A. Wurster | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 84.08 per share. | 09 May 2025 | 15,345 | 177,689 (0%) | 0% | 84.1 | 1,290,188 | Common Stock |
| Nigel J. Murtagh | Chief Risk Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 42.99 per share. | 08 May 2025 | 25,000 | 83,993 (0%) | 0% | 43.0 | 1,074,750 | Common Stock |
| Nigel J. Murtagh | Chief Risk Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 May 2025 | 25,000 | 20,872 | - | - | Nonqualified Stock Option (right to buy) | |
| Nigel J. Murtagh | Chief Risk Officer | Sale of securities on an exchange or to another person at price $ 85.00 per share. | 08 May 2025 | 25,000 | 58,993 (0%) | 0% | 85 | 2,125,000 | Common Stock |
| Jonathan S. Beatty | MD, Head of Advisor Services | Sale of securities on an exchange or to another person at price $ 85.00 per share. | 08 May 2025 | 3,658 | 18,069 (0%) | 0% | 85 | 310,930 | Common Stock |
| Jonathan S. Beatty | MD, Head of Advisor Services | Exercise or conversion of derivative security received from the company (such as an option) at price $ 44.24 per share. | 08 May 2025 | 3,658 | 44,375 (0%) | 0% | 44.2 | 161,830 | Common Stock |
| Jonathan S. Beatty | MD, Head of Advisor Services | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 May 2025 | 3,658 | 0 | - | - | Nonqualified Stock Option (right to buy) | |
| Paul V. Woolway | MD, Chief Banking Officer | Sale of securities on an exchange or to another person at price $ 85.00 per share. | 08 May 2025 | 8,613 | 42,444 (0%) | 0% | 85 | 732,105 | Common Stock |
| Paul V. Woolway | MD, Chief Banking Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 41.98 per share. | 08 May 2025 | 8,613 | 33,767 (0%) | 0% | 42.0 | 361,574 | Common Stock |
| Paul V. Woolway | MD, Chief Banking Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 May 2025 | 8,613 | 0 | - | - | Nonqualified Stock Option (right to buy) | |
| Charles R. Schwab | Director, Co-Chairman | Gift of securities by or to the insider at price $ 0.00 per share. | 07 May 2025 | 62,500 | 59,128,353 (4%) | 0% | 0 | Common Stock | |
| Charles R. Schwab | Director, Co-Chairman | Gift of securities by or to the insider at price $ 0.00 per share. | 07 May 2025 | 6,000 | 59,122,353 (4%) | 0% | 0 | Common Stock | |
| Nigel J. Murtagh | Chief Risk Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 06 May 2025 | 121 | 58,993 (0%) | 0% | 0 | Common Stock | |
| Charles R. Schwab | Director, Co-Chairman | Gift of securities by or to the insider at price $ 0.00 per share. | 05 May 2025 | 75,000 | 59,270,853 (4%) | 0% | 0 | Common Stock | |
| Charles R. Schwab | Director, Co-Chairman | Gift of securities by or to the insider at price $ 0.00 per share. | 05 May 2025 | 80,000 | 59,190,853 (4%) | 0% | 0 | Common Stock | |
| Richard A. Wurster | Director, President & CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 05 May 2025 | 2,877 | 193,034 (0%) | 0% | 0 | Common Stock | |
| Carolyn Schwab-Pomerantz | Director | Sale of securities on an exchange or to another person at price $ 81.14 per share. | 01 May 2025 | 14,400 | 1,531,193 (0%) | 0% | 81.1 | 1,168,428 | Common Stock |
| Carolyn Schwab-Pomerantz | Director | Sale of securities on an exchange or to another person at price $ 81.14 per share. | 01 May 2025 | 9,600 | 496,129 (0%) | 0% | 81.1 | 778,973 | Common Stock |
| Craig Jonathan M. | MD, Head of Investor Services | Sale of securities on an exchange or to another person at price $ 82.00 per share. | 01 May 2025 | 9,559 | 0 (0%) | 0% | 82.0 | 783,853 | Common Stock |
| Jonathan M. Craig | MD, Head of Investor Services | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 May 2025 | 9,559 | 0 | - | - | Nonqualified Stock Option (right to buy) | |
| Craig Jonathan M. | MD, Head of Investor Services | Exercise or conversion of derivative security received from the company (such as an option) at price $ 42.99 per share. | 01 May 2025 | 9,559 | 0 (0%) | 0% | 43.0 | 410,941 | Common Stock |
| Paul V. Woolway | MD, Chief Banking Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 41.98 per share. | 01 May 2025 | 8,614 | 33,767 (0%) | 0% | 42.0 | 361,616 | Common Stock |
| Paul V. Woolway | MD, Chief Banking Officer | Sale of securities on an exchange or to another person at price $ 81.15 per share. | 01 May 2025 | 3,380 | 42,444 (0%) | 0% | 81.1 | 274,274 | Common Stock |
| Paul V. Woolway | MD, Chief Banking Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 May 2025 | 8,614 | 8,613 | - | - | Nonqualified Stock Option (right to buy) | |
| Paul V. Woolway | MD, Chief Banking Officer | Sale of securities on an exchange or to another person at price $ 82.00 per share. | 01 May 2025 | 8,614 | 45,824 (0%) | 0% | 82.0 | 706,361 | Common Stock |
| Charles R. Schwab | Director, Co-Chairman | Gift of securities by or to the insider at price $ 0.00 per share. | 30 Apr 2025 | 625,000 | 59,345,853 (4%) | 0% | 0 | Common Stock | |
| Charles R. Schwab | Director, Co-Chairman | Sale of securities on an exchange or to another person at price $ 79.55 per share. | 28 Apr 2025 | 37,585 | 59,970,853 (4%) | 0% | 79.5 | 2,989,800 | Common Stock |
| Carolyn Schwab-Pomerantz | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 31.37 per share. | 22 Apr 2025 | 6,897 | 8,162 (0%) | 0% | 31.4 | 216,359 | Common Stock |
| Carolyn Schwab-Pomerantz | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Apr 2025 | 6,897 | 0 | - | - | Nonqualified Stock Option (right to buy) | |
| Carolyn Schwab-Pomerantz | Director | Sale of securities on an exchange or to another person at price $ 76.76 per share. | 22 Apr 2025 | 6,897 | 1,545,593 (0%) | 0% | 76.8 | 529,448 | Common Stock |
| Frank C. Herringer | Director | Sale of securities on an exchange or to another person at price $ 74.26 per share. | 21 Apr 2025 | 3,592 | 172,162 (0%) | 0% | 74.3 | 266,731 | Common Stock |
| Frank C. Herringer | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 31.21 per share. | 21 Apr 2025 | 8,548 | 9,204 (0%) | 0% | 31.2 | 266,783 | Common Stock |
| Frank C. Herringer | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Apr 2025 | 8,548 | 0 | - | - | Nonqualified Stock Option (right to buy) | |
| Carolyn Schwab-Pomerantz | Director | Sale of securities on an exchange or to another person at price $ 74.89 per share. | 03 Apr 2025 | 12,253 | 1,547,740 (0%) | 0% | 74.9 | 917,608 | Common Stock |
| Carolyn Schwab-Pomerantz | Director | Sale of securities on an exchange or to another person at price $ 75.22 per share. | 03 Apr 2025 | 1,250 | 505,729 (0%) | 0% | 75.2 | 94,019 | Common Stock |
| Carolyn Schwab-Pomerantz | Director | Sale of securities on an exchange or to another person at price $ 74.90 per share. | 03 Apr 2025 | 8,350 | 506,979 (0%) | 0% | 74.9 | 625,397 | Common Stock |
| Carolyn Schwab-Pomerantz | Director | Sale of securities on an exchange or to another person at price $ 75.20 per share. | 03 Apr 2025 | 2,147 | 1,545,593 (0%) | 0% | 75.2 | 161,450 | Common Stock |
| Paul V. Woolway | MD, Chief Banking Officer | Sale of securities on an exchange or to another person at price $ 77.36 per share. | 01 Apr 2025 | 2,980 | 46,224 (0%) | 0% | 77.4 | 230,540 | Common Stock |
| Paul V. Woolway | MD, Chief Banking Officer | Sale of securities on an exchange or to another person at price $ 77.96 per share. | 01 Apr 2025 | 400 | 45,824 (0%) | 0% | 78.0 | 31,185 | Common Stock |
| Frank C. Herringer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2025 | 1,078 | 1,078 | - | - | Nonqualified Stock Option (right to buy) | |
| Frank C. Herringer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2025 | 266 | 148,579 | - | - | Restricted Stock Units | |
| Stephen A. Ellis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2025 | 435 | 11,220 | - | - | Restricted Stock Units | |
| Marianne C. Brown | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2025 | 483 | 6,094 | - | - | Restricted Stock Units | |
| Charles A. Ruffel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2025 | 1,567 | 1,567 | - | - | Nonqualified Stock Option (right to buy) | |
| Todd M. Ricketts | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 31 Mar 2025 | 290,608 | 525,805 (0%) | 0% | 0 | Common Stock | |
| Paul V. Woolway | MD, Chief Banking Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 41.98 per share. | 24 Mar 2025 | 8,614 | 33,767 (0%) | 0% | 42.0 | 361,616 | Common Stock |
| Paul V. Woolway | MD, Chief Banking Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Mar 2025 | 8,614 | 17,227 | - | - | Nonqualified Stock Option (right to buy) | |
| Paul V. Woolway | MD, Chief Banking Officer | Sale of securities on an exchange or to another person at price $ 80.00 per share. | 24 Mar 2025 | 8,614 | 49,204 (0%) | 0% | 80.0 | 689,129 | Common Stock |
| Charles A. Ruffel | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 43.21 per share. | 14 Mar 2025 | 8,584 | 22,149 (0%) | 0% | 43.2 | 370,915 | Common Stock |
| Charles A. Ruffel | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Mar 2025 | 8,584 | 0 | - | - | Nonqualified Stock Option (right to buy) | |
| Jonathan M. Craig | MD, Head of Investor Services | Sale of securities on an exchange or to another person at price $ 75.59 per share. | 06 Mar 2025 | 23,258 | 0 (0%) | 0% | 75.6 | 1,757,986 | Common Stock |
| Carolyn Schwab-Pomerantz | Director | Sale of securities on an exchange or to another person at price $ 75.59 per share. | 06 Mar 2025 | 9,600 | 515,329 (0%) | 0% | 75.6 | 725,658 | Common Stock |
| Carolyn Schwab-Pomerantz | Director | Sale of securities on an exchange or to another person at price $ 75.58 per share. | 06 Mar 2025 | 14,400 | 1,559,993 (0%) | 0% | 75.6 | 1,088,385 | Common Stock |
| Nigel J. Murtagh | Chief Risk Officer | Sale of securities on an exchange or to another person at price $ 75.38 per share. | 05 Mar 2025 | 15,229 | 59,091 (0%) | 0% | 75.4 | 1,147,936 | Common Stock |
| Paul V. Woolway | MD, Chief Banking Officer | Sale of securities on an exchange or to another person at price $ 75.38 per share. | 05 Mar 2025 | 9,887 | 47,931 (0%) | 0% | 75.4 | 745,253 | Common Stock |
| Michael D. Verdeschi | CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 79,344 | 79,344 | - | - | Nonqualified Stock Option (right to buy) | |
| Charles R. Schwab | Director, Co-Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2025 | 91,200 | 91,200 | - | - | Nonqualified Stock Option (right to buy) | |
| Charles R. Schwab | Director, Co-Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2025 | 66,263 | 66,263 (0%) | 0% | 0 | Common Stock | |
| Charles R. Schwab | Director, Co-Chairman | Payment of exercise price or tax liability using portion of securities received from the company at price $ 79.04 per share. | 01 Mar 2025 | 26,075 | 0 (0%) | 0% | 79.0 | 2,061,098 | Common Stock |
| Walter W. Bettinger | Director, Co-Chairman | Payment of exercise price or tax liability using portion of securities received from the company at price $ 79.04 per share. | 01 Mar 2025 | 96,539 | 956,133 (0%) | 0% | 79.0 | 7,630,925 | Common Stock |
| Walter W. Bettinger | Director, Co-Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2025 | 52,440 | 52,440 | - | - | Nonqualified Stock Option (right to buy) | |
| Walter W. Bettinger | Director, Co-Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2025 | 225,295 | 1,052,672 (0%) | 0% | 0 | Common Stock | |
| Nigel J. Murtagh | Chief Risk Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2025 | 39,216 | 39,216 | - | - | Nonqualified Stock Option (right to buy) | |
| Nigel J. Murtagh | Chief Risk Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 79.04 per share. | 01 Mar 2025 | 11,277 | 74,320 (0%) | 0% | 79.0 | 891,390 | Common Stock |
| Nigel J. Murtagh | Chief Risk Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2025 | 26,506 | 85,597 (0%) | 0% | 0 | Common Stock | |
| Jonathan M. Craig | MD, Head of Investor Services | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2025 | 42,409 | 42,409 (0%) | 0% | 0 | Common Stock | |
| Jonathan M. Craig | MD, Head of Investor Services | Payment of exercise price or tax liability using portion of securities received from the company at price $ 79.05 per share. | 01 Mar 2025 | 19,151 | 0 (0%) | 0% | 79.0 | 1,513,791 | Common Stock |
| Jonathan M. Craig | MD, Head of Investor Services | Exercise or conversion of derivative security received from the company (such as an option) at price $ 42.99 per share. | 01 Mar 2025 | 28,668 | 0 (0%) | 0% | 43.0 | 1,232,437 | Common Stock |
| Jonathan M. Craig | MD, Head of Investor Services | Sale of securities on an exchange or to another person at price $ 79.32 per share. | 01 Mar 2025 | 28,668 | 23,258 (0%) | 0% | 79.3 | 2,273,972 | Common Stock |
| Jonathan M. Craig | MD, Head of Investor Services | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2025 | 28,668 | 9,559 | - | - | Nonqualified Stock Option (right to buy) | |
| Jonathan M. Craig | MD, Head of Investor Services | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2025 | 63,840 | 63,840 | - | - | Nonqualified Stock Option (right to buy) | |
| Peter J. Morgan | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2025 | 27,360 | 27,360 | - | - | Nonqualified Stock Option (right to buy) | |
| Peter J. Morgan | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2025 | 18,554 | 18,554 (0%) | 0% | 0 | Common Stock | |
| Peter J. Morgan | General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 79.04 per share. | 01 Mar 2025 | 8,378 | 10,176 (0%) | 0% | 79.0 | 662,239 | Common Stock |
| Richard A. Wurster | President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 79.04 per share. | 01 Mar 2025 | 34,608 | 195,911 (0%) | 0% | 79.0 | 2,735,589 | Common Stock |
| Richard A. Wurster | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2025 | 92,770 | 230,519 (0%) | 0% | 0 | Common Stock | |
| Richard A. Wurster | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2025 | 231,419 | 231,419 | - | - | Nonqualified Stock Option (right to buy) | |
| Jonathan S. Beatty | MD, Head of Advisor Services | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2025 | 9,482 | 46,463 (0%) | 0% | 0 | Common Stock | |
| Jonathan S. Beatty | MD, Head of Advisor Services | Payment of exercise price or tax liability using portion of securities received from the company at price $ 79.05 per share. | 01 Mar 2025 | 2,088 | 44,375 (0%) | 0% | 79.0 | 165,046 | Common Stock |
| Jonathan S. Beatty | MD, Head of Advisor Services | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2025 | 30,096 | 30,096 | - | - | Nonqualified Stock Option (right to buy) | |
| Paul V. Woolway | MD, Chief Banking Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2025 | 13,254 | 38,407 (0%) | 0% | 0 | Common Stock | |
| Paul V. Woolway | MD, Chief Banking Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2025 | 20,064 | 20,064 | - | - | Nonqualified Stock Option (right to buy) | |
| Paul V. Woolway | MD, Chief Banking Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 79.05 per share. | 01 Mar 2025 | 3,367 | 35,040 (0%) | 0% | 79.0 | 266,145 | Common Stock |
| Paul V. Woolway | MD, Chief Banking Officer | Sale of securities on an exchange or to another person at price $ 79.32 per share. | 01 Mar 2025 | 3,380 | 57,818 (0%) | 0% | 79.3 | 268,118 | Common Stock |
| Charles R. Schwab | Director, Co-Chairman | Sale of securities on an exchange or to another person at price $ 79.14 per share. | 27 Feb 2025 | 55,598 | 59,968,250 (4%) | 0% | 79.1 | 4,399,953 | Common Stock |
| Charles R. Schwab | Director, Co-Chairman | Sale of securities on an exchange or to another person at price $ 81.90 per share. | 21 Feb 2025 | 123,900 | 60,161,458 (4%) | 0% | 81.9 | 10,147,844 | Common Stock |
| Charles R. Schwab | Director, Co-Chairman | Gift of securities by or to the insider at price $ 0.00 per share. | 21 Feb 2025 | 25,000 | 7,347,842 (0%) | 0% | 0 | Common Stock | |
| Charles R. Schwab | Director, Co-Chairman | Gift of securities by or to the insider at price $ 0.00 per share. | 21 Feb 2025 | 62,500 | 60,098,858 (4%) | 0% | 0 | Common Stock | |
| Charles R. Schwab | Director, Co-Chairman | Sale of securities on an exchange or to another person at price $ 82.36 per share. | 21 Feb 2025 | 100 | 60,161,358 (4%) | 0% | 82.4 | 8,236 | Common Stock |
| Charles R. Schwab | Director, Co-Chairman | Sale of securities on an exchange or to another person at price $ 81.96 per share. | 18 Feb 2025 | 124,000 | 60,285,358 (4%) | 0% | 82.0 | 10,163,449 | Common Stock |
| Charles R. Schwab | Director, Co-Chairman | Sale of securities on an exchange or to another person at price $ 81.40 per share. | 18 Feb 2025 | 5,865 | 60,409,358 (4%) | 0% | 81.4 | 477,420 | Common Stock |
| Charles R. Schwab | Director, Co-Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 30.17 per share. | 12 Feb 2025 | 180,506 | 0 (0%) | 0% | 30.2 | 5,445,866 | Common Stock |
| Charles R. Schwab | Director, Co-Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2025 | 180,506 | 0 | - | - | Nonqualified Stock Option (right to buy) | |
| Charles R. Schwab | Director, Co-Chairman | Sale of securities on an exchange or to another person at price $ 81.60 per share. | 12 Feb 2025 | 11,949 | 60,415,223 (4%) | 0% | 81.6 | 975,030 | Common Stock |
| Charles R. Schwab | Director, Co-Chairman | Sale of securities on an exchange or to another person at price $ 81.20 per share. | 12 Feb 2025 | 113,051 | 60,427,172 (4%) | 0% | 81.2 | 9,179,357 | Common Stock |
| Charles R. Schwab | Director, Co-Chairman | Sale of securities on an exchange or to another person at price $ 82.09 per share. | 12 Feb 2025 | 180,506 | 60,540,223 (4%) | 0% | 82.1 | 14,816,907 | Common Stock |
| Walter W. Bettinger | Director, Co-Chairman | Sale of securities on an exchange or to another person at price $ 81.87 per share. | 12 Feb 2025 | 441,797 | 850,209 (0%) | 0% | 81.9 | 36,170,406 | Common Stock |
| Walter W. Bettinger | Director, Co-Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2025 | 464,629 | 0 | - | - | Nonqualified Stock Option (right to buy) | |
| Walter W. Bettinger | Director, Co-Chairman | Sale of securities on an exchange or to another person at price $ 82.66 per share. | 12 Feb 2025 | 22,832 | 827,377 (0%) | 0% | 82.7 | 1,887,186 | Common Stock |
| Walter W. Bettinger | Director, Co-Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 26.39 per share. | 12 Feb 2025 | 464,629 | 1,292,006 (0%) | 0% | 26.4 | 12,261,559 | Common Stock |
| Carolyn Schwab-Pomerantz | Director | Sale of securities on an exchange or to another person at price $ 82.70 per share. | 06 Feb 2025 | 9,600 | 524,929 (0%) | 0% | 82.7 | 793,937 | Common Stock |
| Carolyn Schwab-Pomerantz | Director | Sale of securities on an exchange or to another person at price $ 82.70 per share. | 06 Feb 2025 | 14,400 | 1,574,393 (0%) | 0% | 82.7 | 1,190,909 | Common Stock |
| Arun Sarin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 31.21 per share. | 23 Jan 2025 | 8,548 | 9,204 (0%) | 0% | 31.2 | 266,783 | Common Stock |
| Arun Sarin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Jan 2025 | 8,548 | 0 | - | - | Nonqualified Stock Option (right to buy) | |
| Arun Sarin | Director | Sale of securities on an exchange or to another person at price $ 81.82 per share. | 23 Jan 2025 | 8,548 | 18,617 (0%) | 0% | 81.8 | 699,406 | Common Stock |
| Peter J. Morgan | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 41.98 per share. | 22 Jan 2025 | 14,643 | 14,643 (0%) | 0% | 42.0 | 614,713 | Common Stock |
| Peter J. Morgan | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Jan 2025 | 14,643 | 0 | - | - | Nonqualified Stock Option (right to buy) | |
| Peter J. Morgan | General Counsel | Sale of securities on an exchange or to another person at price $ 80.70 per share. | 22 Jan 2025 | 14,643 | 0 (0%) | 0% | 80.7 | 1,181,709 | Common Stock |
| Carolyn Schwab-Pomerantz | Director | Sale of securities on an exchange or to another person at price $ 74.14 per share. | 02 Jan 2025 | 14,400 | 1,588,793 (0%) | 0% | 74.1 | 1,067,603 | Common Stock |
| Carolyn Schwab-Pomerantz | Director | Sale of securities on an exchange or to another person at price $ 74.14 per share. | 02 Jan 2025 | 9,600 | 534,529 (0%) | 0% | 74.1 | 711,727 | Common Stock |
| Frank C. Herringer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 280 | 147,804 | - | - | Restricted Stock Units | |
| Frank C. Herringer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 1,132 | 1,132 | - | - | Nonqualified Stock Option (right to buy) | |
| Bharat B. Masrani | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 407 | 7,724 | - | - | Restricted Stock Units | |
| Stephen A. Ellis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 458 | 10,748 | - | - | Restricted Stock Units | |
| Marianne C. Brown | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 508 | 5,592 | - | - | Restricted Stock Units | |
| Charles A. Ruffel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 1,646 | 1,646 | - | - | Nonqualified Stock Option (right to buy) | |
| Charles R. Schwab | Director, Co-Chairman | 31 Dec 2024 | 15,650 | 60,586,496 (4%) | 0% | 0 | Common Stock | ||
| Charles R. Schwab | Director, Co-Chairman | 31 Dec 2024 | 15,416 | 60,540,223 (4%) | 0% | 0 | Common Stock | ||
| Charles R. Schwab | Director, Co-Chairman | 31 Dec 2024 | 15,441 | 60,555,639 (4%) | 0% | 0 | Common Stock | ||
| Charles R. Schwab | Director, Co-Chairman | 31 Dec 2024 | 15,416 | 60,571,080 (4%) | 0% | 0 | Common Stock | ||
| A. Ellis Stephen | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 29.93 per share. | 18 Dec 2024 | 2,005 | 7,301 (0%) | 0% | 29.9 | 60,010 | Common Stock |
| Stephen A. Ellis | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Dec 2024 | 2,005 | 0 | - | - | Nonqualified Stock Option (right to buy) | |
| A. Ellis Stephen | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 31.21 per share. | 18 Dec 2024 | 8,548 | 7,301 (0%) | 0% | 31.2 | 266,783 | Common Stock |
| Ellis Stephen A. | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 30.22 per share. | 18 Dec 2024 | 1,997 | 7,301 (0%) | 0% | 30.2 | 60,349 | Common Stock |
| Stephen A. Ellis | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Dec 2024 | 8,548 | 0 | - | - | Nonqualified Stock Option (right to buy) | |
| Ellis Stephen A. | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Dec 2024 | 1,997 | 0 | - | - | Nonqualified Stock Option (right to buy) | |
| Carolyn Schwab-Pomerantz | Director | Sale of securities on an exchange or to another person at price $ 79.28 per share. | 16 Dec 2024 | 5,400 | 1,603,193 (0%) | 0% | 79.3 | 428,100 | Common Stock |
| Carolyn Schwab-Pomerantz | Director | Sale of securities on an exchange or to another person at price $ 79.29 per share. | 16 Dec 2024 | 3,600 | 544,129 (0%) | 0% | 79.3 | 285,435 | Common Stock |
| Carolyn Schwab-Pomerantz | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 26 Nov 2024 | 320 | 1,608,593 (0%) | 0% | 0 | Common Stock | |
| Jonathan Beatty S. | MD, Head of Advisor Services | 25 Nov 2024 | 2,300 | 36,981 (0%) | 0% | 44.2 | 101,752 | Common Stock | |
| Jonathan Beatty S. | MD, Head of Advisor Services | 25 Nov 2024 | 2,300 | 3,658 | - | - | Nonqualified Stock Option (right to buy) | ||
| S. Jonathan Beatty | MD, Head of Advisor Services | 25 Nov 2024 | 2,300 | 18,069 (0%) | 0% | 82.0 | 188,623 | Common Stock | |
| Nigel J. Murtagh | Chief Risk Officer | Sale of securities on an exchange or to another person at price $ 81.17 per share. | 22 Nov 2024 | 12,739 | 59,091 (0%) | 0% | 81.2 | 1,033,972 | Common Stock |
| Christopher V. Dodds | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 33.40 per share. | 18 Nov 2024 | 4,992 | 9,204 (0%) | 0% | 33.4 | 166,733 | Common Stock |
| Christopher V. Dodds | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Nov 2024 | 4,292 | 0 | - | - | Nonqualified Stock Option (right to buy) | |
| Christopher V. Dodds | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Nov 2024 | 4,992 | 0 | - | - | Nonqualified Stock Option (right to buy) | |
| Christopher V. Dodds | Director | Sale of securities on an exchange or to another person at price $ 81.43 per share. | 18 Nov 2024 | 9,284 | 442,807 (0%) | 0% | 81.4 | 755,981 | Common Stock |
| Christopher V. Dodds | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 43.21 per share. | 18 Nov 2024 | 4,292 | 9,204 (0%) | 0% | 43.2 | 185,457 | Common Stock |
| Carolyn Schwab-Pomerantz | Director | Sale of securities on an exchange or to another person at price $ 80.02 per share. | 15 Nov 2024 | 3,600 | 547,729 (0%) | 0% | 80.0 | 288,081 | Common Stock |
| Carolyn Schwab-Pomerantz | Director | Sale of securities on an exchange or to another person at price $ 80.04 per share. | 15 Nov 2024 | 5,400 | 1,608,913 (0%) | 0% | 80.0 | 432,208 | Common Stock |
| Stephen A. Ellis | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 14 Nov 2024 | 35,316 | 75,962 (0%) | 0% | 0 | Common Stock | |
| Jonathan S. Beatty | MD, Head of Advisor Services | 14 Nov 2024 | 2,700 | 36,981 (0%) | 0% | 44.2 | 119,448 | Common Stock | |
| Jonathan S. Beatty | MD, Head of Advisor Services | 14 Nov 2024 | 2,700 | 5,958 | - | - | Nonqualified Stock Option (right to buy) | ||
| Jonathan S. Beatty | MD, Head of Advisor Services | 14 Nov 2024 | 2,700 | 18,069 (0%) | 0% | 81.7 | 220,546 | Common Stock | |
| Charles A. Ruffel | Director | Sale of securities on an exchange or to another person at price $ 78.65 per share. | 13 Nov 2024 | 2,998 | 13,498 (0%) | 0% | 78.6 | 235,779 | Common Stock |
| Jonathan S. Beatty | MD, Head of Advisor Services | 11 Nov 2024 | 2,500 | 18,069 (0%) | 0% | 77.0 | 192,540 | Common Stock | |
| Jonathan S. Beatty | MD, Head of Advisor Services | 11 Nov 2024 | 2,500 | 8,658 | - | - | Nonqualified Stock Option (right to buy) | ||
| Jonathan S. Beatty | MD, Head of Advisor Services | 11 Nov 2024 | 2,500 | 36,981 (0%) | 0% | 44.2 | 110,600 | Common Stock | |
| Paul V. Woolway | MD, Chief Banking Officer | 06 Nov 2024 | 1,321 | 61,198 (0%) | 0% | 0 | Common Stock | ||
| Richard A. Wurster | President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 71.99 per share. | 25 Oct 2024 | 6,479 | 137,749 (0%) | 0% | 72.0 | 466,391 | Common Stock |
| Charles R. Schwab | Director, Co-Chairman | Sale of securities on an exchange or to another person at price $ 70.90 per share. | 21 Oct 2024 | 17,225 | 60,602,146 (4%) | 0% | 70.9 | 1,221,333 | Common Stock |
| Carolyn Schwab-Pomerantz | Director | Sale of securities on an exchange or to another person at price $ 72.22 per share. | 17 Oct 2024 | 3,600 | 551,329 (0%) | 0% | 72.2 | 259,992 | Common Stock |
| Carolyn Schwab-Pomerantz | Director | Sale of securities on an exchange or to another person at price $ 72.14 per share. | 17 Oct 2024 | 20,800 | 1,614,313 (0%) | 0% | 72.1 | 1,500,414 | Common Stock |
| Carolyn Schwab-Pomerantz | Director | Sale of securities on an exchange or to another person at price $ 72.22 per share. | 17 Oct 2024 | 5,400 | 1,635,113 (0%) | 0% | 72.2 | 389,973 | Common Stock |
| Charles R. Schwab | Director, Co-Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 28.44 per share. | 16 Oct 2024 | 62,345 | 0 (0%) | 0% | 28.4 | 1,773,092 | Common Stock |
| Charles R. Schwab | Director, Co-Chairman | Sale of securities on an exchange or to another person at price $ 72.52 per share. | 16 Oct 2024 | 62,345 | 60,619,371 (4%) | 0% | 72.5 | 4,521,484 | Common Stock |
| Charles R. Schwab | Director, Co-Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Oct 2024 | 62,345 | 0 | - | - | Nonqualified Stock Option (right to buy) | |
| Frank C. Herringer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2024 | 2,621 | 2,621 | - | - | Nonqualified Stock Option (right to buy) | |
| Bharat B. Masrani | Director | 01 Oct 2024 | 470 | 7,294 | - | - | Restricted Stock Units | ||
| Stephen A. Ellis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2024 | 2,145 | 2,145 | - | - | Nonqualified Stock Option (right to buy) | |
| Marianne C. Brown | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2024 | 587 | 5,068 | - | - | Restricted Stock Units | |
| Charles A. Ruffel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2024 | 1,906 | 1,906 | - | - | Nonqualified Stock Option (right to buy) | |
| Carolyn Schwab-Pomerantz | Director | Sale of securities on an exchange or to another person at price $ 64.05 per share. | 17 Sep 2024 | 5,400 | 1,640,513 (0%) | 0% | 64.0 | 345,851 | Common Stock |
| Carolyn Schwab-Pomerantz | Director | Sale of securities on an exchange or to another person at price $ 64.06 per share. | 17 Sep 2024 | 3,600 | 554,929 (0%) | 0% | 64.1 | 230,603 | Common Stock |
| Carolyn Schwab-Pomerantz | Director | Sale of securities on an exchange or to another person at price $ 65.08 per share. | 15 Aug 2024 | 7,392 | 1,651,313 (0%) | 0% | 65.1 | 481,060 | Common Stock |
| Carolyn Schwab-Pomerantz | Director | Sale of securities on an exchange or to another person at price $ 65.24 per share. | 15 Aug 2024 | 3,600 | 558,529 (0%) | 0% | 65.2 | 234,873 | Common Stock |
| Carolyn Schwab-Pomerantz | Director | Sale of securities on an exchange or to another person at price $ 65.25 per share. | 15 Aug 2024 | 5,400 | 1,645,913 (0%) | 0% | 65.2 | 352,348 | Common Stock |
| Carolyn Schwab-Pomerantz | Director | Sale of securities on an exchange or to another person at price $ 65.13 per share. | 15 Aug 2024 | 4,928 | 562,129 (0%) | 0% | 65.1 | 320,945 | Common Stock |
| Paul V. Woolway | MD, Chief Banking Officer | 01 Aug 2024 | 1,150 | 61,886 (0%) | 0% | 65.2 | 74,980 | Common Stock | |
| Charles R. Schwab | Director, Co-Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Jul 2024 | 67,386 | 0 | - | - | Nonqualified Stock Option (right to buy) | |
| Charles R. Schwab | Director, Co-Chairman | Sale of securities on an exchange or to another person at price $ 65.11 per share. | 31 Jul 2024 | 67,386 | 60,619,371 (4%) | 0% | 65.1 | 4,387,597 | Common Stock |
| Charles R. Schwab | Director, Co-Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 27.45 per share. | 31 Jul 2024 | 67,386 | 0 (0%) | 0% | 27.5 | 1,849,746 | Common Stock |
| Carolyn Schwab-Pomerantz | Director | Sale of securities on an exchange or to another person at price $ 61.93 per share. | 19 Jul 2024 | 5,100 | 1,659,005 (0%) | 0% | 61.9 | 315,824 | Common Stock |
| Carolyn Schwab-Pomerantz | Director | Sale of securities on an exchange or to another person at price $ 62.65 per share. | 19 Jul 2024 | 100 | 567,057 (0%) | 0% | 62.7 | 6,265 | Common Stock |
| Carolyn Schwab-Pomerantz | Director | Sale of securities on an exchange or to another person at price $ 61.95 per share. | 19 Jul 2024 | 3,500 | 567,157 (0%) | 0% | 61.9 | 216,809 | Common Stock |
| Carolyn Schwab-Pomerantz | Director | Sale of securities on an exchange or to another person at price $ 62.45 per share. | 19 Jul 2024 | 300 | 1,658,705 (0%) | 0% | 62.5 | 18,735 | Common Stock |
| Walter W. Bettinger | Director, Co-Chairman and CEO | Purchase of securities on an exchange or from another person at price $ 66.26 per share. | 17 Jul 2024 | 25,000 | 827,377 (0%) | 0% | 66.3 | 1,656,500 | Common Stock |
| Richard A. Wurster | President | Purchase of securities on an exchange or from another person at price $ 62.05 per share. | 17 Jul 2024 | 10,000 | 144,228 (0%) | 0% | 62.0 | 620,454 | Common Stock |
| Jonathan S. Beatty | MD, Head of Advisor Services | 11 Jul 2024 | 780 | 11,158 | - | - | Nonqualified Stock Option (right to buy) | ||
| Jonathan S. Beatty | MD, Head of Advisor Services | 11 Jul 2024 | 780 | 18,069 (0%) | 0% | 75.0 | 58,502 | Common Stock | |
| Jonathan S. Beatty | MD, Head of Advisor Services | 11 Jul 2024 | 780 | 36,981 (0%) | 0% | 44.2 | 34,507 | Common Stock | |
| Frank C. Herringer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2024 | 2,244 | 2,244 | - | - | Nonqualified Stock Option (right to buy) | |
| Bharat B. Masrani | Director | 01 Jul 2024 | 409 | 6,798 | - | - | Restricted Stock Units | ||
| Stephen A. Ellis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2024 | 1,836 | 3,672 | - | - | Nonqualified Stock Option (right to buy) | |
| Marianne C. Brown | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2024 | 511 | 4,464 | - | - | Restricted Stock Units | |
| Charles A. Ruffel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2024 | 1,632 | 1,632 | - | - | Nonqualified Stock Option (right to buy) | |
| Jonathan S. Beatty | MD, Head of Advisor Services | 01 Jul 2024 | 11,191 | 36,981 (0%) | 0% | 0 | Common Stock | ||
| Carolyn Schwab-Pomerantz | Director | Sale of securities on an exchange or to another person at price $ 72.48 per share. | 20 Jun 2024 | 5,400 | 1,664,105 (0%) | 0% | 72.5 | 391,414 | Common Stock |
| Carolyn Schwab-Pomerantz | Director | Sale of securities on an exchange or to another person at price $ 72.49 per share. | 20 Jun 2024 | 3,600 | 570,657 (0%) | 0% | 72.5 | 260,959 | Common Stock |
| Bernard J. Clark | MD Head of Advisor Services | Exercise or conversion of derivative security received from the company (such as an option) at price $ 52.05 per share. | 12 Jun 2024 | 8,164 | 0 (0%) | 0% | 52.0 | 424,936 | Common Stock |
| Bernard J. Clark | MD Head of Advisor Services | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jun 2024 | 8,164 | 44,251 | - | - | Nonqualified Stock Option (right to buy) | |
| Bernard J. Clark | MD Head of Advisor Services | Sale of securities on an exchange or to another person at price $ 75.00 per share. | 12 Jun 2024 | 8,164 | 121,665 (0%) | 0% | 75 | 612,300 | Common Stock |
| Marianne C. Brown | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 May 2024 | 4,496 | 4,496 | - | - | Nonqualified Stock Option (right to buy) | |
| Gerri K. Martin-Flickinger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 May 2024 | 1,809 | 4,305 (0%) | 0% | 0 | Common Stock | |
| Gerri K. Martin-Flickinger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 May 2024 | 4,496 | 4,496 | - | - | Nonqualified Stock Option (right to buy) | |
| Charles A. Ruffel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 May 2024 | 1,809 | 16,450 (0%) | 0% | 0 | Common Stock | |
| Charles A. Ruffel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 May 2024 | 4,496 | 4,496 | - | - | Nonqualified Stock Option (right to buy) | |
| Carolyn Schwab-Pomerantz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 May 2024 | 1,809 | 8,162 (0%) | 0% | 0 | Common Stock | |
| Carolyn Schwab-Pomerantz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 May 2024 | 4,496 | 4,496 | - | - | Nonqualified Stock Option (right to buy) | |
| John K. Adams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 May 2024 | 4,496 | 4,496 | - | - | Nonqualified Stock Option (right to buy) | |
| John K. Adams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 May 2024 | 1,809 | 46,933 (0%) | 0% | 0 | Common Stock | |
| Christopher V. Dodds | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 May 2024 | 4,496 | 4,496 | - | - | Nonqualified Stock Option (right to buy) | |
| Christopher V. Dodds | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 May 2024 | 1,809 | 9,204 (0%) | 0% | 0 | Common Stock | |
| Frank C. Herringer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 May 2024 | 4,496 | 4,496 | - | - | Nonqualified Stock Option (right to buy) | |
| Frank C. Herringer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 May 2024 | 1,809 | 9,204 (0%) | 0% | 0 | Common Stock | |
| Paula A. Sneed | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 May 2024 | 1,809 | 6,611 (0%) | 0% | 0 | Common Stock | |
| Paula A. Sneed | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 May 2024 | 4,496 | 4,496 | - | - | Nonqualified Stock Option (right to buy) | |
| Brian Michael Levitt | Director | 28 May 2024 | 4,496 | 4,496 | - | - | Nonqualified Stock Option (right to buy) | ||
| Brian Michael Levitt | Director | 28 May 2024 | 1,809 | 7,279 (0%) | 0% | 0 | Common Stock | ||
| Arun Sarin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 May 2024 | 1,809 | 9,204 (0%) | 0% | 0 | Common Stock | |
| Arun Sarin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 May 2024 | 4,496 | 4,496 | - | - | Nonqualified Stock Option (right to buy) | |
| Bharat B. Masrani | Director | 28 May 2024 | 1,809 | 7,279 (0%) | 0% | 0 | Common Stock | ||
| Bharat B. Masrani | Director | 28 May 2024 | 4,496 | 4,496 | - | - | Nonqualified Stock Option (right to buy) | ||
| Joan T. Dea | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 May 2024 | 4,496 | 4,496 | - | - | Nonqualified Stock Option (right to buy) | |
| Joan T. Dea | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 May 2024 | 1,809 | 26,724 (0%) | 0% | 0 | Common Stock | |
| Todd M. Ricketts | Director | 28 May 2024 | 4,496 | 4,496 | - | - | Nonqualified Stock Option (right to buy) | ||
| Todd M. Ricketts | Director | 28 May 2024 | 1,809 | 235,197 (0%) | 0% | 0 | Common Stock | ||
| Stephen A. Ellis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 May 2024 | 4,496 | 4,496 | - | - | Nonqualified Stock Option (right to buy) | |
| Stephen A. Ellis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 May 2024 | 1,809 | 9,204 (0%) | 0% | 0 | Common Stock | |
| Bernard J. Clark | MD Head of Advisor Services | Exercise or conversion of derivative security received from the company (such as an option) at price $ 42.99 per share. | 28 May 2024 | 28,670 | 0 (0%) | 0% | 43.0 | 1,232,523 | Common Stock |
| Bernard J. Clark | MD Head of Advisor Services | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 May 2024 | 28,670 | 0 | - | - | Nonqualified Stock Option (right to buy) | |
| Bernard J. Clark | MD Head of Advisor Services | Sale of securities on an exchange or to another person at price $ 71.88 per share. | 28 May 2024 | 2,816 | 121,665 (0%) | 0% | 71.9 | 202,428 | Common Stock |
| Bernard J. Clark | MD Head of Advisor Services | Sale of securities on an exchange or to another person at price $ 70.91 per share. | 28 May 2024 | 74,615 | 124,481 (0%) | 0% | 70.9 | 5,290,718 | Common Stock |
| Marianne C. Brown | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 May 2024 | 1,809 | 14,289 (0%) | 0% | 0 | Common Stock | |
| Brian Michael Levitt | Director | 22 May 2024 | 197 | 5,470 (0%) | 0% | 78.7 | 15,506 | Common Stock | |
| Bharat B. Masrani | Director | 22 May 2024 | 197 | 5,470 (0%) | 0% | 78.7 | 15,506 | Common Stock | |
| Charles R. Schwab | Director, Co-Chairman | Gift of securities by or to the insider at price $ 0.00 per share. | 20 May 2024 | 64,100 | 60,619,371 (4%) | 0% | 0 | Common Stock | |
| Carolyn Schwab-Pomerantz | Director | Sale of securities on an exchange or to another person at price $ 78.41 per share. | 20 May 2024 | 5,400 | 1,669,505 (0%) | 0% | 78.4 | 423,434 | Common Stock |
| Carolyn Schwab-Pomerantz | Director | Sale of securities on an exchange or to another person at price $ 78.41 per share. | 20 May 2024 | 3,600 | 574,257 (0%) | 0% | 78.4 | 282,293 | Common Stock |
| Brian Michael Levitt | Director | 17 May 2024 | 241 | 5,829 (0%) | 0% | 77.9 | 18,779 | Common Stock | |
| Brian Michael Levitt | Director | 17 May 2024 | 162 | 5,667 (0%) | 0% | 78.5 | 12,716 | Common Stock | |
| Bharat B. Masrani | Director | 17 May 2024 | 162 | 5,667 (0%) | 0% | 78.5 | 12,716 | Common Stock | |
| Bharat B. Masrani | Director | 17 May 2024 | 241 | 5,829 (0%) | 0% | 77.9 | 18,779 | Common Stock | |
| Charles R. Schwab | Director, Co-Chairman | Sale of securities on an exchange or to another person at price $ 78.08 per share. | 14 May 2024 | 58,065 | 60,683,471 (4%) | 0% | 78.1 | 4,533,709 | Common Stock |
| Charles R. Schwab | Director, Co-Chairman | Sale of securities on an exchange or to another person at price $ 76.89 per share. | 14 May 2024 | 65,360 | 60,741,536 (4%) | 0% | 76.9 | 5,025,700 | Common Stock |
| Carolyn Schwab-Pomerantz | Director | Sale of securities on an exchange or to another person at price $ 76.13 per share. | 09 May 2024 | 26,315 | 1,674,570 (0%) | 0% | 76.1 | 2,003,429 | Common Stock |
| Charles R. Schwab | Director, Co-Chairman | Gift of securities by or to the insider at price $ 0.00 per share. | 08 May 2024 | 65,790 | 60,840,896 (4%) | 0% | 0 | Common Stock | |
| Charles R. Schwab | Director, Co-Chairman | Gift of securities by or to the insider at price $ 0.00 per share. | 08 May 2024 | 34,000 | 60,806,896 (4%) | 0% | 0 | Common Stock | |
| Carolyn Schwab-Pomerantz | Director | Sale of securities on an exchange or to another person at price $ 76.38 per share. | 06 May 2024 | 13,113 | 1,700,885 (0%) | 0% | 76.4 | 1,001,635 | Common Stock |
| Carolyn Schwab-Pomerantz | Director | Sale of securities on an exchange or to another person at price $ 76.38 per share. | 06 May 2024 | 13,113 | 1,700,885 (0%) | 0% | 76.4 | 1,001,635 | Common Stock |
| Charles R. Schwab | Director, Co-Chairman | Sale of securities on an exchange or to another person at price $ 75.51 per share. | 03 May 2024 | 66,225 | 60,972,476 (4%) | 0% | 75.5 | 5,000,425 | Common Stock |
| Charles R. Schwab | Director, Co-Chairman | Sale of securities on an exchange or to another person at price $ 76.40 per share. | 03 May 2024 | 65,790 | 60,906,686 (4%) | 0% | 76.4 | 5,026,474 | Common Stock |
| Charles R. Schwab | Director, Co-Chairman | Sale of securities on an exchange or to another person at price $ 74.96 per share. | 26 Apr 2024 | 59,905 | 61,098,607 (4%) | 0% | 75.0 | 4,490,419 | Common Stock |
| Charles R. Schwab | Director, Co-Chairman | Sale of securities on an exchange or to another person at price $ 74.78 per share. | 26 Apr 2024 | 59,906 | 61,038,701 (4%) | 0% | 74.8 | 4,480,010 | Common Stock |
| Peter B. Crawford | CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 28.44 per share. | 24 Apr 2024 | 5,481 | 0 (0%) | 0% | 28.4 | 155,880 | Common Stock |
| Peter B. Crawford | CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Apr 2024 | 5,481 | 0 | - | - | Nonqualified Stock Option (right to buy) | |
| Peter B. Crawford | CFO | Sale of securities on an exchange or to another person at price $ 75.51 per share. | 24 Apr 2024 | 5,481 | 60,567 (0%) | 0% | 75.5 | 413,855 | Common Stock |
| Charles R. Schwab | Director, Co-Chairman | Gift of securities by or to the insider at price $ 0.00 per share. | 22 Apr 2024 | 26,900 | 61,158,512 (4%) | 0% | 0 | Common Stock | |
| Charles R. Schwab | Director, Co-Chairman | Sale of securities on an exchange or to another person at price $ 74.62 per share. | 22 Apr 2024 | 89,275 | 30,641,981 (2%) | 0% | 74.6 | 6,661,308 | Common Stock |
| Stephen A. Ellis | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 25.01 per share. | 19 Apr 2024 | 10,511 | 7,395 (0%) | 0% | 25.0 | 262,880 | Common Stock |
| Stephen A. Ellis | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 28.79 per share. | 19 Apr 2024 | 2,054 | 7,395 (0%) | 0% | 28.8 | 59,135 | Common Stock |
| Stephen A. Ellis | Director | Sale of securities on an exchange or to another person at price $ 73.21 per share. | 19 Apr 2024 | 14,750 | 108,574 (0%) | 0% | 73.2 | 1,079,774 | Common Stock |
| Stephen A. Ellis | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Apr 2024 | 10,511 | 0 | - | - | Nonqualified Stock Option (right to buy) | |
| Stephen A. Ellis | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Apr 2024 | 2,185 | 0 | - | - | Nonqualified Stock Option (right to buy) | |
| Stephen A. Ellis | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Apr 2024 | 2,054 | 0 | - | - | Nonqualified Stock Option (right to buy) | |
| Stephen A. Ellis | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 27.32 per share. | 19 Apr 2024 | 2,185 | 7,395 (0%) | 0% | 27.3 | 59,694 | Common Stock |
| Joseph R. Martinetto | COO | 18 Apr 2024 | 13,353 | 246,433 (0%) | 0% | 0 | Common Stock | ||
| Carolyn Schwab-Pomerantz | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Apr 2024 | 7,482 | 0 | - | - | Nonqualified Stock Option (right to buy) | |
| Carolyn Schwab-Pomerantz | Director | Sale of securities on an exchange or to another person at price $ 73.47 per share. | 18 Apr 2024 | 7,482 | 1,719,398 (0%) | 0% | 73.5 | 549,667 | Common Stock |
| Carolyn Schwab-Pomerantz | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 28.44 per share. | 18 Apr 2024 | 7,482 | 6,353 (0%) | 0% | 28.4 | 212,788 | Common Stock |
| Carolyn Schwab-Pomerantz | Director | Sale of securities on an exchange or to another person at price $ 73.17 per share. | 18 Apr 2024 | 5,400 | 1,713,998 (0%) | 0% | 73.2 | 395,102 | Common Stock |
| Carolyn Schwab-Pomerantz | Director | Sale of securities on an exchange or to another person at price $ 73.16 per share. | 18 Apr 2024 | 3,600 | 577,857 (0%) | 0% | 73.2 | 263,366 | Common Stock |
| Joseph R. Martinetto | COO | 16 Apr 2024 | 43,000 | 41,414 (0%) | 0% | 70.8 | 3,045,595 | Common Stock | |
| Arun Sarin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Apr 2024 | 5,011 | 0 | - | - | Nonqualified Stock Option (right to buy) | |
| Arun Sarin | Director | Sale of securities on an exchange or to another person at price $ 71.11 per share. | 16 Apr 2024 | 5,011 | 18,617 (0%) | 0% | 71.1 | 356,322 | Common Stock |
| Arun Sarin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 25.01 per share. | 16 Apr 2024 | 5,011 | 7,395 (0%) | 0% | 25.0 | 125,325 | Common Stock |
| Mark A. Goldfarb | Director | Sale of securities on an exchange or to another person at price $ 70.82 per share. | 16 Apr 2024 | 6,700 | 20,317 (0%) | 0% | 70.8 | 474,488 | Common Stock |
| Mark A. Goldfarb | Director | Sale of securities on an exchange or to another person at price $ 71.48 per share. | 16 Apr 2024 | 400 | 19,917 (0%) | 0% | 71.5 | 28,593 | Common Stock |
| Nigel J. Murtagh | Chief Risk Officer | Sale of securities on an exchange or to another person at price $ 72.40 per share. | 16 Apr 2024 | 10,000 | 71,446 (0%) | 0% | 72.4 | 723,975 | Common Stock |
| Nigel J. Murtagh | Chief Risk Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 16 Apr 2024 | 133 | 71,313 (0%) | 0% | 0 | Common Stock | |
| Peter B. Crawford | CFO | Sale of securities on an exchange or to another person at price $ 71.02 per share. | 16 Apr 2024 | 6,114 | 60,567 (0%) | 0% | 71.0 | 434,215 | Common Stock |
| Peter B. Crawford | CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Apr 2024 | 5,482 | 5,481 | - | - | Nonqualified Stock Option (right to buy) | |
| Peter B. Crawford | CFO | Sale of securities on an exchange or to another person at price $ 73.46 per share. | 16 Apr 2024 | 5,482 | 60,567 (0%) | 0% | 73.5 | 402,708 | Common Stock |